Ultrasonic bath 12.5L digital, ambient + 5 to 70°C, inc. lid, s/s basket, SD Card, drain tubing and 1 bottle of M2 solution
- Known as:
- Ultrasonic bath 12.5L digital, ambient + 5 70°C, inc. lid, s/s basket, SD Card, drain tubing 1 bottle M2 buffer
- Catalog number:
- xub12
- Product Quantity:
- EUR
- Category:
- -
- Supplier:
- Biosan
- Gene target:
- Ultrasonic bath 12.5L digital ambient + 5 70° inc. lid / basket Card drain tubing and 1 bottle M2 solution
Related genes to: Ultrasonic bath 12.5L digital, ambient + 5 to 70°C, inc. lid, s/s basket, SD Card, drain tubing and 1 bottle of M2 solution
- Gene:
- A2ML1 NIH gene
- Name:
- alpha-2-macroglobulin like 1
- Previous symbol:
- CPAMD9
- Synonyms:
- FLJ25179, p170
- Chromosome:
- 12p13.31
- Locus Type:
- gene with protein product
- Date approved:
- 2005-07-20
- Date modifiied:
- 2018-04-17
- Gene:
- AARS2 NIH gene
- Name:
- alanyl-tRNA synthetase 2, mitochondrial
- Previous symbol:
- AARSL
- Synonyms:
- KIAA1270, bA444E17.1
- Chromosome:
- 6p21.1
- Locus Type:
- gene with protein product
- Date approved:
- 2003-05-08
- Date modifiied:
- 2018-05-03
- Gene:
- ABCB1 NIH gene
- Name:
- ATP binding cassette subfamily B member 1
- Previous symbol:
- PGY1, MDR1, CLCS
- Synonyms:
- P-gp, CD243, GP170, ABC20
- Chromosome:
- 7q21.12
- Locus Type:
- gene with protein product
- Date approved:
- 1986-01-01
- Date modifiied:
- 2015-11-13
- Gene:
- ABCC4 NIH gene
- Name:
- ATP binding cassette subfamily C member 4
- Previous symbol:
- -
- Synonyms:
- MRP4, EST170205, MOAT-B, MOATB
- Chromosome:
- 13q32.1
- Locus Type:
- gene with protein product
- Date approved:
- 1999-10-26
- Date modifiied:
- 2019-04-23
- Gene:
- ABCD3 NIH gene
- Name:
- ATP binding cassette subfamily D member 3
- Previous symbol:
- PXMP1
- Synonyms:
- PMP70, ZWS2
- Chromosome:
- 1p21.3
- Locus Type:
- gene with protein product
- Date approved:
- 1992-03-03
- Date modifiied:
- 2015-11-13
Related products to: Ultrasonic bath 12.5L digital, ambient + 5 to 70°C, inc. lid, s/s basket, SD Card, drain tubing and 1 bottle of M2 solution
"DRAIN VALVE 1"" BP " Prod. Code P"Fish_tail" soft stirring disc for 0.4, 1, 3 and 7l reactor"Fish_tail" soft stirring disc for 0.4, 1, 3 and 7l reactor, modified geometry and material for softer stirring"NO_OX TUBING 1_8""OD X 5 FT " Prod. Code K"TUBING PTFE 1_16""OD 10_FT " Prod. Code K"TUBING PTFE 1_4""OD 10_FT " Prod. Code K"TUBING PTFE 1_8""OD 10_FT " Prod. Code K"Two-in-One Image Scanner for Microscope Slides, Filmstrips/Film Slides
Specifically designed for converting microscope slides and films/film slides into digital data formats with high resolution"'Enduroä PAGE 2D System, includes 2D insert and PAGE System components'Enduroä PAGE Electroblotting System, includes the blotting insert and PAGE system components'Orbit 300 Multipurpose Digital Vortexe Flat platform (30 x 30 cm) with non-slip rubber mat for use with Orbit 300 Shaker'Orbit 300 Multipurpose Digital Vortexe Microplate platform for 4 plates, for use with Orbit 300 Shaker'Orbit 300 Multipurpose Digital Vortexe Universal spring loaded clamp platform forflasks, bottles, tube racks, etc. for use with Orbit 300 Shaker'VX-200 Vortex Mixer Optional head attachment for 24 x 1.5/2.0 ml tubes, 24 x 0.5 ml tubes and 32 x 0.2 ml tubes (or 4 tube strips)'VX-200 Vortex Mixer Optional head attachment for 8 x 15 ml and 8 x 12/13 mm diameter tubes Related articles to: Ultrasonic bath 12.5L digital, ambient + 5 to 70°C, inc. lid, s/s basket, SD Card, drain tubing and 1 bottle of M2 solution
- Swine acute diarrhea syndrome coronavirus (SADS-CoV) is a bat-origin porcine enteric alphacoronavirus first identified in Guangdong, China in 2017, which causes severe watery diarrhea and high mortality in neonatal piglets, leading to in substantial economic losses to the global swine industry. Here, we report that SADS-CoV nsp10 functions as an IFN-λ1 antagonist. Specifically, nsp10 suppressed IFN-λ1 production independently of its zinc finger domains. Furthermore, nsp10 inhibits MAVS- and IRF1-driven IFN-λ1 expression within the RLR signaling pathway. Nsp10 blocks poly (I:C)-induced nuclear translocation of IRF1, although no direct physical interaction is detected between the two proteins. Pull-down assays combined with mass spectrometry identified hnRNPU as a nsp10-interacting protein and their direct interaction was verified by co-immunoprecipitation (Co-IP). hnRNPU alone inhibits IFN-λ1 production and synergizes with nsp10 to enhance this suppression, consequently facilitating SADS-CoV replication. Collectively, our findings uncover a previously unrecognized immune evasion mechanism employed by SADS-CoV and provide a potential therapeutic target for controlling coronavirus infections. - Source: PubMed
Publication date: 2026/09/06
Wei XiaonaZhao YukunLiu JiaxinLi JingminZhong ChunhuiZhao KeyuCao YongchangXue Chunyi - The effect of diet on genetic regulation in humans remains largely unexplored. Here, we investigate gene-diet interactions in a unique group of healthy individuals (N = 200) who alternate between omnivory and dietary restriction of animal products for religious reasons. Using longitudinal proteomic and genotype data, we identify diet-responsive cis-pQTLs and highlight regulatory effects on LBR and MSRA, proteins involved in cholesterol and methionine metabolism respectively. LBR-associated cis-pQTL rs74148404 colocalizes with obesity exclusively under dietary restriction, suggesting diet-dependent modulation of genetic risk. We also show that a diet-dependent cis-pQTL for metabolic regulator FGF21 colocalizes with eosinophil and platelet traits pointing to diet-sensitive immunometabolic signalling. By parallel profiling of a continuously omnivorous control group (N = 211), we uncover seasonally dynamic genetic regulation for proteins linked to apoptosis in immune system pathways (MAVS, CASP3, PDLIM7, IL12RB1), effects likely masked by animal product restriction. These findings reveal dynamic diet- and season-sensitive regulatory mechanisms with implications for precision nutrition and individualized disease prevention strategies, and underscore the need to integrate environmental context into genetic studies of health and disease. - Source: PubMed
Publication date: 2026/08/08
Simistiras AlexandrosBocher OzvanEmmanouil ChristinaSkoulakis AnargyrosGlentis StavrosScarmeas NikolaosZeggini EleftheriaRouskas KonstantinosDimas Antigone S - Autophagy-associated protein 13 (ATG13) plays a pivotal role in regulating the assembly of the autophagy initiation complex. However, the function and mechanism of action of ATG13 during influenza virus infection remain incompletely understood. This study elucidates that ATG13 restricts influenza A virus (IAV) replication while potentiating the activation of the type I interferon (IFN-I) pathway. Mechanistically, coimmunoprecipitation assays revealed that ATG13 interacts with MAVS and recruits the E3 ubiquitin ligase ASB1 to catalyze K63-linked polyubiquitination at the K348 residue, thereby amplifying the downstream antiviral signaling cascade. Furthermore, through dual-luciferase reporter assays and pharmacological inhibition of autophagy, we confirmed that this novel immunomodulatory function of ATG13 is independent of the canonical autophagy pathway. The present study identifies ATG13 as a novel host restriction factor against IAV and reveals a nonautophagic role for ATG13 in antiviral innate immunity. - Source: PubMed
Publication date: 2026/09/07
Lu YiyuanChen JialeXiao HuiminLi JinzeWang HaixuLiang TianhaoWang JiaruiPang XueyiCheng MingyangSun YuCui TongPu FeiyangZhan JiaxingZhao YiboBao HongyuYang WentaoJiang YanlongYang GuilianWang JianzhongCao XinWang ChunfengBai XueZeng Yan - This study aims to investigate the inhibitory effect of baicalein on cervical cancer driven by persistent human papillomavirus(HPV) infection and clarify its regulatory mechanism on the mitochondrial antiviral signaling protein(MAVS)-interferon regulatory factor 3(IRF3)-interferon-β(IFN-β) signaling pathway, so as to provide experimental evidence for the clinical transformation of baicalein. AutoDock Vina software was used for molecular docking to predict the binding modes and binding energies of baicalein with MAVS and HPV16 E6 proteins. HPV18-positive HeLa cells and HPV16-positive CaSki cells were cultured in vitro. They were divided into the control group and baicalein groups with low dose(10 μmol·L~(-1)) and high dose(40 μmol·L~(-1)). Meanwhile, the silent MAVS cell model was constructed and divided into the negative control small interfering RNA group(siNC) group, MAVS small interfering RNA(siMAVS) group, siNC + baicalein with high dose(H) group, and siMAVS + baicalein-H group. Cell proliferation and apoptosis were detected by colony formation assay, CCK-8 assay, and flow cytometry. The protein expressions of the MAVS-IRF3-IFN-β pathway and HPV16 E6 were detected by Western blot. A nude mouse model bearing CaSki cell xenografts of cervical cancer was established and randomly divided into five groups with six mice in each group: model group, baicalein with low dose(L) group(10 mg·kg~(-1)), baicalein-H group(40 mg·kg~(-1)), siMAVS + baicalein-H group, and siMAVS + model group. Modeling and administration were completed after anesthesia with pentobarbital sodium. Tumor volume was detected every three days; tumor tissues were stripped and weighed at the end of the experiment; the expressions of pathway-related proteins and oncoproteins in tumor tissues were detected by immunohistochemistry. The results show that the binding energies of baicalein with MAVS and HPV16 E6 proteins are-6.65 and-8.82 kcal·mol~(-1), respectively, with good binding activity. In in vitro experiments, baicalein inhibits the proliferation of HeLa and CaSki cells and promotes their apoptosis in a dose-dependent manner, significantly up-regulating the protein expressions of MAVS, p-IRF3/IRF3, and IFN-β, as well as down-regulating the protein expression of HPV16 E6. After MAVS silencing, the in vitro anti-tumor effect and regulatory pathway effect of baicalein are significantly reversed. In in vivo experiments, there are statistically significant differences in tumor volume, tumor weight, and the expression of related proteins among all groups. The tumor volume and weight in the baicalein-L and baicalein-H groups are significantly lower than those in the model group, with the tumor inhibition rates of 47.22% and 73.61%, respectively. The expressions of MAVS, p-IRF3, and IFN-β in tumor tissues are increased, while the expressions of HPV16 E6 and Ki67 proliferation antigen(Ki67) are decreased. After MAVS silencing, the in vivo tumor inhibition rate of baicalein decreases to 22.22%, and its regulatory pathway effect is significantly weakened. In conclusion, baicalein can directly bind to MAVS and HPV16 E6 proteins and exert an anti-cervical cancer effect driven by persistent HPV infection via activating the MAVS-IRF3-IFN-β mitochondrial antiviral signaling pathway and inhibiting the function of HPV16 E6 oncoprotein. MAVS is a key target for baicalein to exert its anti-tumor effect. - Source: PubMed
Chen JinKang Heng-YuanJiang Yu-HanChen Chen-Chen - The NLRP3 inflammasome is a central signaling pathway of innate immunity that orchestrates host defense and inflammatory responses through the activation of proinflammatory cytokines and the induction of pyroptotic cell death. Accumulating evidence indicates that NLRP3 functions within an extensive network of innate immune and cell death pathways. Reciprocal interactions between NLRP3 and other pattern-recognition receptor pathways, including Toll-like receptors, DNA-sensing cGAS-STING signaling, and RNA-sensing RIG-I/MDA5-MAVS signaling, shape the magnitude and duration of inflammatory responses during pathogen infection. Moreover, substantial crosstalk exists between NLRP3 and other inflammasomes and programmed cell death pathways, reflecting the integrated nature of cellular stress and inflammatory signaling. In this review, we summarize recent advances in our understanding of the molecular mechanisms that mediate these interactions, focusing on shared signaling components, organelle dynamics, posttranslational modifications, and feedback regulatory circuits. We further discuss how these signaling networks contribute to infectious and inflammatory diseases and highlight key unanswered questions and emerging areas of investigation that may guide the development of therapies targeting inflammasome-associated pathologies. - Source: PubMed
Publication date: 2026/09/02
Xiao NanyangLu ZexuanCooper Destiny KChen Jueqi